10-QPeriod: Q2 FY2023

Cigna Group Quarterly Report for Q2 Ended Jun 30, 2023

Filed August 3, 2023For Securities:CI

Summary

The Cigna Group reported solid top-line growth for the second quarter of 2023, with total revenues increasing by 7% to $48.6 billion, driven by strong performance in both Evernorth Health Services and Cigna Healthcare segments. While the company experienced a slight decrease in shareholders' net income to $1.46 billion from $1.56 billion in the prior year's quarter, this was largely due to lower adjusted income from operations and the absence of earnings from divested businesses. Evernorth Health Services demonstrated robust growth in adjusted revenues, up 10%, fueled by specialty pharmacy and increased client services. Cigna Healthcare also saw a 12% increase in adjusted revenues, supported by customer growth and higher premium rates. The company's capital position remains strong, with significant liquidity and a stable debt-to-capitalization ratio. Strategic investments in healthcare services, including a notable investment in VillageMD, signal continued focus on expanding care delivery capabilities and long-term growth.

Financial Highlights

47 data points
Beta

Revenue

$48.59B

31.2% Gross Margin

Net Income

$1.46B

3.0% Net Margin

EPS (Diluted)

$4.92

Total Assets

$150.05B

Cash & Equivalents

$9.64B

Free Cash Flow

$2.49B

Financial Statements
Beta
Revenue$48.59B
Cost of Revenue$33.44B
Gross Profit$15.14B
SG&A Expenses$3.43B
Operating Income$2.22B
Interest Expense$350.00M
Net Income$1.46B
EPS (Basic)$4.96
EPS (Diluted)$4.92
Shares Outstanding (Diluted)296.88M

Key Highlights

  • 1Total revenues increased by 7% year-over-year to $48.6 billion for the second quarter of 2023.
  • 2Shareholders' net income slightly decreased to $1.46 billion from $1.56 billion year-over-year, primarily due to a decline in adjusted income from operations.
  • 3Evernorth Health Services experienced a 10% increase in adjusted revenues, driven by growth in specialty pharmacy and care delivery solutions.
  • 4Cigna Healthcare's adjusted revenues grew by 12%, supported by customer growth and higher premium rates.
  • 5The company made a significant strategic investment of $2.7 billion in VillageMD during the first half of 2023.
  • 6Cash flows from operating activities were strong at $7.5 billion for the first six months of 2023, a substantial increase from $3.3 billion in the prior year.
  • 7The company repurchased $1.1 billion of its common stock in the first six months of 2023, down from $2.3 billion in the same period last year.

Frequently Asked Questions

Revenue growth was primarily driven by increases in both Evernorth Health Services and Cigna Healthcare. Evernorth saw strong performance from its specialty pharmacy and care delivery solutions, while Cigna Healthcare benefited from customer growth and higher premium rates.

Shareholders' net income saw a slight decrease year-over-year, from $1.56 billion to $1.46 billion. This was primarily attributed to lower adjusted income from operations, influenced by the absence of earnings from divested businesses and a decrease in net investment income.

Cigna Group continues to invest strategically in healthcare services, as evidenced by its $2.7 billion investment in VillageMD and a $437 million investment in CarepathRx Health Systems Solutions. The company also prioritizes returning capital to shareholders through dividends and share repurchases.

The company maintains strong liquidity with $9.7 billion in cash and short-term investments as of June 30, 2023, and significant undrawn committed capacity under its revolving credit agreements. Operating cash flows were robust, supporting operational needs, debt service, dividends, and strategic investments.